Local effects of recombinant rat interleukin-6 on the peripheral nervous system

Immunology

Volumn 97, Issue 4, 1999, Pages 582-587

  Deretzi, G ^a   Pelidou, S H ^a   Zou, L P ^a   Quiding, C ^a   Zhu, Jie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; GUILLAIN BARRE SYNDROME; IMMUNOPATHOGENESIS; INFLAMMATION; MACROPHAGE; MALE; NONHUMAN; PERINEURIUM; PRIORITY JOURNAL; RAT; SCIATIC NERVE; T LYMPHOCYTE;

ANIMALS; DEMYELINATING DISEASES; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-6; MACROPHAGES; MALE; NEURITIS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SCIATIC NERVE; T-LYMPHOCYTE SUBSETS;

EID: 0032792193     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00808.x     Document Type: Article

References (31)

1. 1. HIRANO T. (1994) Interleukin 6. In: The Cytokine Handbook (ed. A. W. Thomson), 2nd edn, p. 145. Academic Press, London.
2. 2. HIRANO T. (1998) Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16, 249.
3. 3. GIJBELS K., BROCKE S., ABRAMS J. & STEIMAN L. (1995). Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated level of IL-6 bioactivity in central nervous system and circulation. Mol Med 1, 795.
4. 4. XU X.J., HAO J.X., ANDELL-JONSSON S., POLI V., BARTFAI T. & WIESENFELD-HALLIN Z. (1997) Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 9, 1028.
5. 5. RODRIGUEZ M., PAVELCO K.D., MCKINXEY C.W. & LEIBOWITZ J.L. (1994). Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol 153, 3811.
6. 6. TILG H., DINARELLO C.A. & MIER J. (1997) IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 18, 428.
7. 7. BAUMANN H. & GAULDIE J. (1994). The acute response. Immunol Today 15, 74.
8. 8. FATTORI E., CAPPELLETTI M., COSTA P. et al. (1994) Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 180, 1243.
9. 9. MIZUHARA H., O'NEIL E., SEKI N. et al. (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin-6. J Exp Med 179, 1529.
10. 10. STRASSMANN G., FONG M., WINDSOR S. & NETA R. (1993) The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 5, 285.
11. 11. WELLER M., STEVENS A., SOMMER N., MELMS A., DICHANS J. & WITHOLTER H. (1991) Comparative analysis of cytokine patterns in immunological disorders. J Neurol Sci 104, 215.
12. 12. SIVIERI S., FERRERINI A.M., LOLLI F. et al. (1997) Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci 147, 93.
13. 13. BARTON B. (1997) IL-6: Insights into novel biological activities. Clin Immunol Immunopharmacol 85, 16.
14. 14. DYCK P.J., LAIS A.C., HANSEN S.M. et al. (1982) Technique assessment of demyclination from etidoneurial injection. Exp Neurol 77, 359.
15. 15. SAID G. & HONTEBEYRIE-JOCKOWICZ M. (1992) Nerve lesions induced by macrophage activation. Res Immunol 143, 589.
16. 16. HUGUS R., POWELL H.C., BRAHENY S.L. & BROSTOFF S. (1985) Endoneural injection of antisera to myelin antigens. Muscle Nerve 8, 516.
17. 17. OLSSON T., DIENER P., LJUNGDAHL A., HOJEBERG B., VAN DER MEIDE P.H. & KRISTENSSON K. (1992) Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity 13, 117.
18. 18. OLSSON T., SUN J.B., SOLDERS G. et al. (1993) Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J Neurol Sci 117, 130.
19. 19. GRIFFIN J., STOLL G., YAN C., TYOR W. & CORNBLATH D. (1990) Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 27 (suppl.), 64.
20. 20. AKIRA S. & KISHIMITO T. (1996) Role of interleukin-6 in macrophage function. Curr Opin Hematol 3, 87.
21. 21. MARUO N., MORITA L, SHIRAO M. & MUROTA S. (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131, 710.
22. 22. SPIES J.M., WESTALD K.W., BONNER J.G. & POLLARD J.D. (1995) Intraneural activated T cells cause focal breakdown of the blood-nerve barrier. Brain 118, 857.
23. 23. REDFORD E.J., HALL S.M. & SMITH K.J. ( 1995) Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain 118, 869.
24. 24. WAAGE A., BRANDTZAEG P., HALSTENSEN A., KIERULF P. & ESPEVIK T. (1989) The complex pattern of cytokines in serum from patients with meningococeal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169, 333.
25. 25. HALL S.M. & GREGSON N.A. (1971) The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myclinated peripheral nerve fibres of the adult mouse. J Cell Sci 9, 769.
26. 26. GROSS J.L., JENSES J., SAID G. & SUMME A.J. (1984) An experimental model of protease induced focal demyelination. Neurol 34 (suppl. 1), 131.
27. 27. WATSON S.L., WESTLAND K. & POLLAND J.D. (1994) An electrophysiological and histological study of trypsin induced demyelination. J Neurol Sci 126, 116.
28. 28. HARTUNG H.P., KIEFER R., COLD R. & TOYKA K. (1996) Autoimmunity in the peripheral nervous system. Raillière's Clin Neurol 5, 1.
29. 29. OLSSON T., HOLMDALHI R., KLARESKONG I., & FORSUM U. (1983) Ia-expressing cells and T lymphocytes of different subsets in the peripheral nerve tissue during experimental allergic neuritis in Lewis rats. Scand J Immunol 18, 339.
30. 30. LAING T. & WEISS A. (1988) Evidence for IL-2 independent proliferation in human T cells. J Immunol 140, 1056.
31. 31. KUHWEIDE R., VAN DAMME J. & CEUPPENS J.L. (1990) Tumor necrosis factor-alpha and interleukin-6 synergistically induce T cell growth. Eur J Immunol 20, 1019.